| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INC COM | 563,200 | 16,243,000 | 9.48% | Put | |
| 2 | QUOTIENT LTD | 2,237,771 | 10,831,000 | 6.32% | ||
| 3 | SANOFI | 210,000 | 8,492,000 | 4.95% | Put | |
| 4 | CERNER CORP | 149,200 | 7,068,000 | 4.12% | Put | |
| 5 | GLAXOSMITHKLINE PLC | 180,811 | 6,963,000 | 4.06% | ||
| 6 | GLAXOSMITHKLINE PLC | 170,000 | 6,547,000 | 3.82% | Call | |
| 7 | KONINKLIJKE PHILIPS N V | 209,502 | 6,404,000 | 3.74% | ||
| 8 | HILL ROM HLDGS INC | 106,594 | 5,984,000 | 3.49% | ||
| 9 | TABULA RASA HEALTHCARE INC COM | 388,054 | 5,813,000 | 3.39% | ||
| 10 | EDWARDS LIFESCIENCES CORP | 55,000 | 5,154,000 | 3.01% | ||
| 11 | CARDINAL HEALTH INC | 70,000 | 5,038,000 | 2.94% | Put | |
| 12 | CARDINAL HEALTH INC | 68,885 | 4,958,000 | 2.89% | ||
| 13 | LILLY ELI & CO | 67,000 | 4,928,000 | 2.88% | ||
| 14 | ZIMMER BIOMET HLDGS INC | 46,723 | 4,822,000 | 2.81% | ||
| 15 | WALGREENS BOOTS ALLIANCE INC | 57,000 | 4,717,000 | 2.75% | Put | |
| 16 | AMGEN INC | 30,000 | 4,386,000 | 2.56% | Put | |
| 17 | ZOETIS INC | 80,000 | 4,282,000 | 2.50% | Put | |
| 18 | ALLERGAN PLC | 20,000 | 4,200,000 | 2.45% | Put | |
| 19 | ADVANCED ACCELERATOR APPLIC | 153,332 | 4,103,000 | 2.39% | ||
| 20 | ACLARIS THERAPEUTICS INC COM | 138,441 | 3,757,000 | 2.19% | ||
| 21 | ADAMIS PHARMACEUTICALS CORP | 1,051,063 | 3,311,000 | 1.93% | ||
| 22 | NATUS MEDICAL INC. | 90,865 | 3,162,000 | 1.84% | ||
| 23 | KONINKLIJKE PHILIPS N V | 100,000 | 3,057,000 | 1.78% | Call | |
| 24 | RIGEL PHARMACEUTICAL INC | 1,263,390 | 3,007,000 | 1.75% | ||
| 25 | AMGEN INC | 20,000 | 2,924,000 | 1.71% | Call | |
| 26 | BOSTON SCIENTIFIC CORP | 120,500 | 2,606,000 | 1.52% | Call | |
| 27 | UNITEDHEALTH GROUP INC | 16,187 | 2,591,000 | 1.51% | ||
| 28 | HUMANA | 12,500 | 2,550,000 | 1.49% | Put | |
| 29 | AETNA INC NEW | 20,000 | 2,480,000 | 1.45% | ||
| 30 | BOSTON SCIENTIFIC CORP | 113,500 | 2,455,000 | 1.43% | ||
| 31 | PERRIGO CO PLC | 29,329 | 2,441,000 | 1.42% | ||
| 32 | CHEMOCENTRYX INC | 325,250 | 2,407,000 | 1.40% | ||
| 33 | AMGEN INC | 16,430 | 2,402,000 | 1.40% | ||
| 34 | STRYKER CORP | 20,000 | 2,396,000 | 1.40% | Put | |
| 35 | IMMUNOMEDICS INC | 506,978 | 1,861,000 | 1.09% | ||
| 36 | ACTINIUM PHARMACEUTICALS INC | 1,649,078 | 1,443,000 | 0.84% | ||
| 37 | ADAMAS PHARMACEUTICALS INC | 69,215 | 1,170,000 | 0.68% | ||
| 38 | SAREPTA THERAPEUTICS INC | 35,000 | 960,000 | 0.56% | Put | |
| 39 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 91,413 | 950,000 | 0.55% | ||
| 40 | AEGLEA BIOTHERAPEUTICS INC COM | 188,485 | 820,000 | 0.48% | ||
| 41 | FORWARD PHARMA A/S | 51,246 | 769,000 | 0.45% | ||
| 42 | OASMIA PHARMACEUTICAL AB | 182,270 | 512,000 | 0.30% | ||
| 43 | BIOPHARMX CORP COM | 1,143,400 | 428,000 | 0.25% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-17-001124, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
